BRCA1 and pachyonychia congenita: Our findings further indicate that additional DNA repair genes besides BRCA1/2 and ATM may be included in germline testing of metastatic PC patients, as other DNA repair genes showed a strong association to worse patient outcomes (Figs. 3, 4).